What’s Vulnerable › Vulnerabilities

CVE-2022-26235

• Severity: high (CVSS 7.8 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.2% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2022-10-06 · updated 2026-06-17
• Weakness: CWE-276

Description

A vulnerability was discovered in the Remisol Advance v2.0.12.1 and below for the Normand Message Server. On installation, the permissions set by Remisol Advance allow non-privileged users to overwrite and/or manipulate executables and libraries that run as the elevated SYSTEM user on Windows.

Affected products

• Beckmancoulter Remisol Advance: through 2.0.12.1

References

• https://pastebin.com/amgw9pE7
• https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance
• https://pastebin.com/amgw9pE7
• https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance

Get alerted when CVE-2022-26235 or the next vulnerability affects your stack